Bliss GVS Pharma fixes book closure from July 9 for final dividend
Bliss GVS Pharma Limited has fixed July 8, 2026, as the record date for a ₹1.00 per share final dividend, subject to shareholder approval at the 41st AGM on July 15, 2026. The share transfer books will remain closed from July 9 to July 15, 2026. The company also detailed e-voting schedules and TDS regulations for the dividend payout.

*this image is generated using AI for illustrative purposes only.
Bliss GVS Pharma Limited has fixed Wednesday, July 08, 2026, as the record date to determine shareholder entitlement for the final dividend for the financial year ended March 31, 2026. The Register of Members and Share Transfer Books will remain closed from Thursday, July 09, 2026, to Wednesday, July 15, 2026, for the 41st Annual General Meeting and dividend payment. The Board of Directors has recommended a final dividend of ₹1.00 per equity share, subject to approval at the meeting. If approved, payment will be made on or before Friday, August 14, 2026.
The 41st Annual General Meeting is scheduled to be held on Wednesday, July 15, 2026, at 11:00 AM through Video Conferencing or Other Audio-Visual Means. The agenda includes the adoption of financial statements for FY2025-26, the declaration of the final dividend, and the re-appointment of Mr. Narsimha Shibroor Kamath as Managing Director & CEO.
E-Voting and Participation Details
The company has provided remote e-voting facilities for shareholders. The remote e-voting period commences at 9:00 AM on Sunday, July 12, 2026, and concludes at 5:00 PM on Tuesday, July 14, 2026. Shareholders eligible to vote as on the cut-off date of Wednesday, July 08, 2026, may cast their votes electronically during this period or via e-voting during the meeting. The facility for remote e-voting is available to at least 1,000 members on a first-come, first-served basis, excluding large shareholders and promoters.
Tax Deduction on Dividend
The company stated that tax will be deducted at source (TDS) on the dividend payment. For resident shareholders, TDS will be deducted at 10% if PAN is registered, or 20% if not. No tax will be deducted if the total dividend does not exceed ₹5,000. Non-resident shareholders and other entities must submit relevant documents, such as Tax Residency Certificates, to avail of lower treaty rates. Shareholders must submit necessary declarations like Form 15G or 15H by Wednesday, July 08, 2026, to avoid higher deduction.
Historical Stock Returns for Bliss GVS Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.68% | +6.94% | +56.50% | +167.45% | +216.45% | +328.88% |
What factors might influence shareholder approval of the final dividend and the re-appointment of the Managing Director & CEO?
How could the TDS regulations impact dividend attractiveness for retail versus institutional investors?
What strategic initiatives is Bliss GVS Pharma likely to prioritize in FY2026-27 following the AGM?

































